FDA Approves Trevena’s IV Opioid for Short-Term Acute Pain ManagementAcute Pain, Approvals, Controlled Substances, Drug Enforcement Agency (DEA), FDA, FDA/Regulatory, Hospitals, New Chemical Entities, Opioid AgonistsThe U.S. Food and Drug Administration approved Trevena’s Olinvyk as a new intravenous opioid for short-term management of acute pain in a hospital setting. Read more August 13, 2020/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/08/FDA-Approves-Trevenas-IV-Opioid-for-Short-Term-Acute-Pain-Management-BioSpace-8-13-20.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2020-08-13 11:31:362020-08-13 11:31:36FDA Approves Trevena’s IV Opioid for Short-Term Acute Pain Management